Myocardial fibrosis identified as new therapeutic target

(European Society of Cardiology) Myocardial fibrosis could be a future therapeutic target after researchers found it correlated with adverse cardiovascular outcomes in patients with obstructive sleep apnoea referred for cardiac magnetic resonance. The study was presented today at EuroCMR 2016 by Dr Yaron Fridman, a cardiology fellow at the Heart and Vascular Institute, University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania, US.